Research ArticleExperimental Studies

Activity and Therapeutic Potential of ORI-1001 Antisense Oligonucleotide on Human Papillomavirus Replication Utilizing a Model of Dysplastic Human Epithelium

SAMINA ALAM, JENNIFER BROMBERG-WHITE, MARGARET MCLAUGHLIN-DRUBIN, ELLORA SEN, JASON M. BODILY and CRAIG MEYERS
Anticancer Research March 2005, 25 (2A) 765-777;

Article Information

vol. 25 no. 2A 765-777
PubMed 
15868908
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 13, 2005
  • Accepted February 18, 2005
  • Published online March 1, 2005.
Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. SAMINA ALAM,
  2. JENNIFER BROMBERG-WHITE,
  3. MARGARET MCLAUGHLIN-DRUBIN,
  4. ELLORA SEN,
  5. JASON M. BODILY and
  6. CRAIG MEYERS
  1. Department of Microbiology and Immunology, The Pennsylvania State University, College of Medicine, Hershey, PA 17033, U.S.A.
  1. Correspondence to: Craig Meyers, Department of Microbiology and Immunology, 500 University Drive, The Pennsylvania State University College of Medicine, Hershey, PA, 17033, U.S.A. Tel: (717)531-6240, Fax: (717)531-4600, e-mail: cmm10{at}psu.edu

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Activity and Therapeutic Potential of ORI-1001 Antisense Oligonucleotide on Human Papillomavirus Replication Utilizing a Model of Dysplastic Human Epithelium
SAMINA ALAM, JENNIFER BROMBERG-WHITE, MARGARET MCLAUGHLIN-DRUBIN, ELLORA SEN, JASON M. BODILY, CRAIG MEYERS
Anticancer Research Mar 2005, 25 (2A) 765-777;
Twitter logo Facebook logo Mendeley logo

Jump to section